Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Summary for Mega-Scandal

Mega-Scandal: Opioid Crisis
Description: This list shows cases in which companies paid penalties of $25 million or more in cases in which they were charged with engaging in practices that contributed to the opioid epidemic.
Penalty Total since 2000$72,748,409,664
Number of Penalty Records: 86
Note: The totals here are adjusted to account for the fact that each current parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Purdue Pharma$9,214,000,0004
McKesson$8,640,666,6666
Walgreens Boots Alliance$7,489,373,5838
Cardinal Health$7,119,666,6667
AmerisourceBergen$6,962,666,6664
CVS Health$5,484,000,0002
Johnson & Johnson$5,479,500,0006
Teva Pharmaceutical Industries$5,403,929,6339
Walmart$3,414,673,8554
AbbVie$2,896,032,5957

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
Company sort iconCurrent ParentCurrent Parent IndustryPrimary Offense TypeYearAgencyPenalty Amount
Walmart StoresWalmartretailingoff-label or unapproved promotion of medical products2022MULTI-AG$3,100,000,000
Walmart Inc.Walmartretailingoff-label or unapproved promotion of medical products2022FL-AG$215,000,000
WalmartWalmartretailingoff-label or unapproved promotion of medical products2022AL-AG$44,200,000
WalmartWalmartretailingoff-label or unapproved promotion of medical products2024MD-AG$55,473,855
Walgreens CorporationWalgreens Boots AllianceretailingControlled Substances Act violation2013DEA$80,000,000
Walgreens Boots Alliance, Inc.Walgreens Boots Allianceretailingoff-label or unapproved promotion of medical products2023KY-AG$102,000,000
WalgreensWalgreens Boots Allianceretailingoff-label or unapproved promotion of medical products2022FL-AG$680,000,000
WalgreensWalgreens Boots Allianceretailingoff-label or unapproved promotion of medical products2022MULTI-AG$5,700,000,000
WalgreensWalgreens Boots Allianceretailingoff-label or unapproved promotion of medical products2023CA-SFCA$229,610,000
WalgreensWalgreens Boots Allianceretailingoff-label or unapproved promotion of medical products2023MI-AG$338,000,000
WalgreensWalgreens Boots Allianceretailingoff-label or unapproved promotion of medical products2023NV-AG$285,000,000
WalgreensWalgreens Boots Allianceretailingoff-label or unapproved promotion of medical products2024MD-AG$74,763,583
Teva Pharmaceuticals, Ltd.Teva Pharmaceutical Industriespharmaceuticalsoff-label or unapproved promotion of medical products2022NY-AG$313,343,793
Teva Pharmaceuticals, Inc.Teva Pharmaceutical Industriespharmaceuticalsoff-label or unapproved promotion of medical products2023KY-AG$71,477,474
Teva PharmaceuticalsTeva Pharmaceutical IndustriespharmaceuticalsControlled Substances Act violation2019OK-AG$85,000,000
Teva PharmaceuticalsTeva Pharmaceutical Industriespharmaceuticalsoff-label or unapproved promotion of medical products2022MULTI-AG$4,250,000,000
Teva Pharmaceutical Industries Ltd.Teva Pharmaceutical Industriespharmaceuticalsoff-label or unapproved promotion of medical products2022TX-AG$225,000,000
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriespharmaceuticalsoff-label or unapproved promotion of medical products2022FL-AG$278,826,499
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriespharmaceuticalsoff-label or unapproved promotion of medical products2022WV-AG$83,000,000
Teva ParmaceuticalsTeva Pharmaceutical Industriespharmaceuticalsoff-label or unapproved promotion of medical products2022CA-SFCA$27,000,000
TevaTeva Pharmaceutical Industriespharmaceuticalsoff-label or unapproved promotion of medical products2024MD-AG$70,281,867
Reckitt Benckiser Group plcReckitt Benckiserhousehold and personal care productsControlled Substances Act violation2019USAO$1,347,000,000
Reckitt Benckiser GroupReckitt Benckiserhousehold and personal care productsControlled Substances Act violation2019MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $200,000,000
Reckitt Benckiser GroupReckitt Benckiserhousehold and personal care productsFalse Claims Act and related2019MULTI-AG$400,000,000
Purdue Pharma LPPurdue Pharmapharmaceuticalsfraud2020DOJ_CIVIL$8,344,000,000
Purdue PharmaPurdue PharmapharmaceuticalsControlled Substances Act violation2019OK-AG$270,000,000
Purdue Frederick Company Inc.Purdue PharmapharmaceuticalsFalse Claims Act and related2007USAO$600,000,000
Purdue Frederick Company Inc.Purdue PharmapharmaceuticalsFalse Claims Act and related2007MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $160,000,000
Publicis Health off-label or unapproved promotion of medical products2024MULTI-AG$350,000,000
Practice Fusion Inc.Allscripts Healthcare Solutionsinformation technologykickbacks and bribery2020DOJ_CIVIL$145,000,000
PharMerica Corp.KKR & Co.private equity (including portfolio companies)False Claims Act and related2015DOJ_CIVIL$31,500,000
McKinsey & CompanyMcKinseybusiness servicesoff-label or unapproved promotion of medical products2021MULTI-AG$573,000,000
McKinsey & Co.McKinseybusiness servicesoff-label or unapproved promotion of medical products2024private lawsuit-federal$207,000,000
McKinsey & Co.McKinseybusiness servicesoff-label or unapproved promotion of medical products2024private lawsuit-federal$39,500,000
McKesson CorporationMcKessonwholesalersControlled Substances Act violation2017DEA$150,000,000
McKesson CorporationMcKessonwholesalersControlled Substances Act violation2019WV-AG$37,000,000
McKesson CorporationMcKessonwholesalersoff-label or unapproved promotion of medical products2021MULTI-AG$8,001,000,000
McKesson Corp.McKessonwholesalersoff-label or unapproved promotion of medical products2022WA-AG$172,666,667
McKesson Corp.McKessonwholesalersoff-label or unapproved promotion of medical products2022WV-AG$133,333,333
McKesson Corp.McKessonwholesalersproduct safety violation2022private lawsuit-federal$146,666,666
Mallinckrodt LLCMallinckrodtpharmaceuticalsControlled Substances Act violation2017DEA$35,000,000
MallinckrodtMallinckrodtpharmaceuticalsControlled Substances Act violation2020MULTI-AG$1,600,000,000
Kroger Co.Krogerretailingoff-label or unapproved promotion of medical products2022NM-AG$58,500,000
KrogerKrogerretailingoff-label or unapproved promotion of medical products2023WV-AG$68,000,000
KrogerKrogerretailingoff-label or unapproved promotion of medical products2023MULTI-AG$1,370,000,000
KrogerKrogerretailingoff-label or unapproved promotion of medical products2024WA-AG$47,500,000
K-VA-T Food StoresK-VA-T Food Storesretailingoff-label or unapproved promotion of medical products2023TN-AG$44,500,000
Johnson & JohnsonJohnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2021MULTI-AG$5,000,000,000
Johnson & JohnsonJohnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2022NH-AG$40,500,000
Johnson & JohnsonJohnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2024WA-AG$149,500,000
Janssen Pharmaceuticals/Johnson & JohnsonJohnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2022NH-AG$40,500,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonpharmaceuticalsproduct safety violation2022private lawsuit-federal$150,000,000
Janssen PharmaceuticalsJohnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2022WV-AG$99,000,000
Insys Therapeutics False Claims Act and related2019DOJ_CIVIL$225,000,000
Indivior SolutionsIndivior PLCpharmaceuticalsFalse Claims Act and related2020DOJ_CIVIL$589,000,000
Indivior plcIndivior PLCpharmaceuticalsoff-label or unapproved promotion of medical products2021MULTI-AG$300,000,000
Hikma PharmaceuticalsHikma Pharmaceuticalspharmaceuticalsoff-label or unapproved promotion of medical products2024MULTI-AG$150,000,000
Endo International plcEndo Internationalpharmaceuticalsoff-label or unapproved promotion of medical products2022MULTI-AG$450,000,000
Endo Health Solutions Inc. Endo Internationalpharmaceuticalsdrug or medical equipment safety violation2024DOJ_CIVIL$1,536,000,000
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc.Endo Internationalpharmaceuticalsoff-label or unapproved promotion of medical products2022FL-AG$65,000,000
Endo Health Solutions Inc.Endo Internationalpharmaceuticalsdrug or medical equipment safety violation2024DOJ_CIVIL$464,900,000
Endo Health Solutions and Endo PharmaceuticalsEndo Internationalpharmaceuticalsoff-label or unapproved promotion of medical products2022FL-AG$65,000,000
Endo Health SolutionsEndo Internationalpharmaceuticalsoff-label or unapproved promotion of medical products2021NY-AG$50,000,000
Dunn Meadow LLC Controlled Substances Act violation2022USAO$50,000,000
CVS Health Corporation and CVS Pharmacy, Inc.CVS Healthretailingoff-label or unapproved promotion of medical products2022FL-AG$484,000,000
CVSCVS Healthretailingoff-label or unapproved promotion of medical products2022MULTI-AG$5,000,000,000
Cencora off-label or unapproved promotion of medical products2024AL-AG$110,000,000
Cardinal Health, Inc.Cardinal Healthwholesalersoff-label or unapproved promotion of medical products2022WA-AG$172,666,667
Cardinal Health Inc.Cardinal Healthwholesalersoff-label or unapproved promotion of medical products2021MULTI-AG$6,489,000,000
Cardinal Health Inc.Cardinal Healthwholesalersoff-label or unapproved promotion of medical products2022WV-AG$133,333,333
Cardinal Health Inc.Cardinal Healthwholesalersproduct safety violation2022private lawsuit-federal$146,666,666
Cardinal HealthCardinal HealthwholesalersControlled Substances Act violation2016DEA$34,000,000
Cardinal HealthCardinal HealthwholesalersControlled Substances Act violation2008USAO$34,000,000
Cardinal HealthCardinal Healthwholesalersoff-label or unapproved promotion of medical products2024AL-AG$110,000,000
Amneal PharmaceuticalsAmneal Pharmaceuticalspharmaceuticalsoff-label or unapproved promotion of medical products2024MULTI-AG$272,500,000
AmerisourceBergen CorporationAmerisourceBergenwholesalersoff-label or unapproved promotion of medical products2021MULTI-AG$6,510,000,000
AmerisourceBergen Corp.AmerisourceBergenwholesalersoff-label or unapproved promotion of medical products2022WA-AG$172,666,667
AmerisourceBergenAmerisourceBergenwholesalersoff-label or unapproved promotion of medical products2022WV-AG$133,333,333
AmerisourceBergenAmerisourceBergenwholesalersproduct safety violation2022private lawsuit-federal$146,666,666
Allergan PLCAbbViepharmaceuticalsoff-label or unapproved promotion of medical products2023KY-AG$48,666,145
Allergan Ltd. et al.AbbViepharmaceuticalsoff-label or unapproved promotion of medical products2022FL-AG$134,200,000
Allergan Finance LLCAbbViepharmaceuticalsoff-label or unapproved promotion of medical products2021NY-AG$200,000,000
AllerganAbbViepharmaceuticalsoff-label or unapproved promotion of medical products2022WV-AG$78,000,000
AllerganAbbViepharmaceuticalsoff-label or unapproved promotion of medical products2022MULTI-AG$2,370,000,000
AllerganAbbViepharmaceuticalsoff-label or unapproved promotion of medical products2022CA-SFCA$27,000,000
AllerganAbbViepharmaceuticalsoff-label or unapproved promotion of medical products2024MD-AG$38,166,450
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.